OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Utility of the Ba/F3 cell system for exploring on‐target mechanisms of resistance to targeted therapies for lung cancer
T. Koga, Kenichi Suda, Tetsuya Mitsudomi
Cancer Science (2022) Vol. 113, Iss. 3, pp. 815-827
Open Access | Times Cited: 35
T. Koga, Kenichi Suda, Tetsuya Mitsudomi
Cancer Science (2022) Vol. 113, Iss. 3, pp. 815-827
Open Access | Times Cited: 35
Showing 1-25 of 35 citing articles:
Recent progress in targeted therapy for non-small cell lung cancer
Yanxia Xiao, Pu Liu, Jie Wei, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 43
Yanxia Xiao, Pu Liu, Jie Wei, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 43
Targeted Inhibitors of EGFR: Structure, Biology, Biomarkers, and Clinical Applications
Nina Shaban, Dmitri Kamashev, Aleksandra Emelianova, et al.
Cells (2023) Vol. 13, Iss. 1, pp. 47-47
Open Access | Times Cited: 18
Nina Shaban, Dmitri Kamashev, Aleksandra Emelianova, et al.
Cells (2023) Vol. 13, Iss. 1, pp. 47-47
Open Access | Times Cited: 18
Mapping kinase domain resistance mechanisms for the MET receptor tyrosine kinase via deep mutational scanning
Gabriella O. Estevam, Edmond M. Linossi, J. N. K. Rao, et al.
(2025)
Open Access
Gabriella O. Estevam, Edmond M. Linossi, J. N. K. Rao, et al.
(2025)
Open Access
Identification of a novel TOP2B::AFF2 fusion gene in B-cell acute lymphoblastic leukemia
Tao Liu, Yang Wang, Xizhou An, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Tao Liu, Yang Wang, Xizhou An, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Mapping kinase domain resistance mechanisms for the MET receptor tyrosine kinase via deep mutational scanning
Gabriella O. Estevam, Edmond M. Linossi, J. N. K. Rao, et al.
eLife (2025) Vol. 13
Open Access
Gabriella O. Estevam, Edmond M. Linossi, J. N. K. Rao, et al.
eLife (2025) Vol. 13
Open Access
A comprehensive overview of the heterogeneity of EGFR exon 20 variants in NSCLC and (pre)clinical activity to currently available treatments
Fenneke Zwierenga, Bianca van Veggel, Anke van den Berg, et al.
Cancer Treatment Reviews (2023) Vol. 120, pp. 102628-102628
Open Access | Times Cited: 11
Fenneke Zwierenga, Bianca van Veggel, Anke van den Berg, et al.
Cancer Treatment Reviews (2023) Vol. 120, pp. 102628-102628
Open Access | Times Cited: 11
Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 Insertion
Akira Hamada, Kenichi Suda, Masaya Nishino, et al.
Journal of Thoracic Oncology (2023) Vol. 19, Iss. 1, pp. 71-79
Closed Access | Times Cited: 9
Akira Hamada, Kenichi Suda, Masaya Nishino, et al.
Journal of Thoracic Oncology (2023) Vol. 19, Iss. 1, pp. 71-79
Closed Access | Times Cited: 9
Conserved regulatory motifs in the juxtamembrane domain and kinase N-lobe revealed through deep mutational scanning of the MET receptor tyrosine kinase domain
Gabriella O. Estevam, Edmond M. Linossi, Christian B. Macdonald, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 9
Gabriella O. Estevam, Edmond M. Linossi, Christian B. Macdonald, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 9
CRISPR/Cas9-edited ROS1 + non-small cell lung cancer cell lines highlight differential drug sensitivity in 2D vs 3D cultures while reflecting established resistance profiles
Marc Terrones, Christophe Deben, Felicia Rodrigues-Fortes, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Marc Terrones, Christophe Deben, Felicia Rodrigues-Fortes, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Conserved regulatory motifs in the juxtamembrane domain and kinase N-lobe revealed through deep mutational scanning of the MET receptor tyrosine kinase domain
Gabriella O. Estevam, Edmond M. Linossi, Christian B. Macdonald, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Gabriella O. Estevam, Edmond M. Linossi, Christian B. Macdonald, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Design, synthesis, and evaluation of dual EGFR/AURKB inhibitors as anticancer agents for non-small cell lung cancer
Sonali Kurup, Dayna Gesinski, Kaitlin Assaad, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 100, pp. 129612-129612
Open Access | Times Cited: 2
Sonali Kurup, Dayna Gesinski, Kaitlin Assaad, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 100, pp. 129612-129612
Open Access | Times Cited: 2
Multiplexed, multimodal profiling of the intracellular activity, interactions, and druggability of protein variants using LABEL-seq
Jessica J. Simon, Douglas M. Fowler, Dustin J. Maly
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Jessica J. Simon, Douglas M. Fowler, Dustin J. Maly
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Clinical Relevance of Patient-Derived Organoid of Surgically Resected Lung Cancer as an In Vitro Model for Biomarker and Drug Testing
T. Koga, Junichi Soh, Akira Hamada, et al.
JTO Clinical and Research Reports (2023) Vol. 4, Iss. 9, pp. 100554-100554
Open Access | Times Cited: 5
T. Koga, Junichi Soh, Akira Hamada, et al.
JTO Clinical and Research Reports (2023) Vol. 4, Iss. 9, pp. 100554-100554
Open Access | Times Cited: 5
Characterization of BRAFThr599dup Mutation as a Targetable Driver Mutation Identified in Lung Adenocarcinoma by Comprehensive Genomic Profiling
Hirofumi Watanabe, Yusuke Inoue, Masato Karayama, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 1
Hirofumi Watanabe, Yusuke Inoue, Masato Karayama, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 1
GLI1 confers resistance to PARP inhibitors by activating the DNA damage repair pathway
Hiroshi Ikeuchi, Yusuke Matsuno, Rika Kusumoto‐Matsuo, et al.
Oncogene (2024) Vol. 43, Iss. 41, pp. 3037-3048
Closed Access | Times Cited: 1
Hiroshi Ikeuchi, Yusuke Matsuno, Rika Kusumoto‐Matsuo, et al.
Oncogene (2024) Vol. 43, Iss. 41, pp. 3037-3048
Closed Access | Times Cited: 1
Pre-clinical modelling of ROS1+ non-small cell lung cancer
Marc Terrones, Ken Op de Beeck, Guy Van Camp, et al.
Lung Cancer (2023) Vol. 180, pp. 107192-107192
Open Access | Times Cited: 2
Marc Terrones, Ken Op de Beeck, Guy Van Camp, et al.
Lung Cancer (2023) Vol. 180, pp. 107192-107192
Open Access | Times Cited: 2
Mapping EGFR Exon 20 Resistance Mutations: An Intricate Landscape
Surbhi Singhal, David R. Gandara, Jonathan W. Riess
Journal of Thoracic Oncology (2024) Vol. 19, Iss. 1, pp. 10-12
Open Access
Surbhi Singhal, David R. Gandara, Jonathan W. Riess
Journal of Thoracic Oncology (2024) Vol. 19, Iss. 1, pp. 10-12
Open Access
Discovery of a first-in-class protein degrader for the c-ros oncogene 1 (ROS1)
Jiawen Yang, Yifan Wu, Qiaoliang Zhu, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107590-107590
Closed Access
Jiawen Yang, Yifan Wu, Qiaoliang Zhu, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107590-107590
Closed Access
eLife assessment: Conserved regulatory motifs in the juxtamembrane domain and kinase N-lobe revealed through deep mutational scanning of the MET receptor tyrosine kinase domain
Volker Dötsch
(2024)
Open Access
Volker Dötsch
(2024)
Open Access
Author response: Conserved regulatory motifs in the juxtamembrane domain and kinase N-lobe revealed through deep mutational scanning of the MET receptor tyrosine kinase domain
Gabriella O. Estevam, Edmond M. Linossi, Christian B. Macdonald, et al.
(2024)
Open Access
Gabriella O. Estevam, Edmond M. Linossi, Christian B. Macdonald, et al.
(2024)
Open Access
Reviewer #2 (Public Review): Conserved regulatory motifs in the juxtamembrane domain and kinase N-lobe revealed through deep mutational scanning of the MET receptor tyrosine kinase domain
(2024)
Open Access
(2024)
Open Access
Hypoxia-Inducible Factor-1 activated by PIM1 assembles a non-canonical transcription complex and resultant regulon that drives progression of JAK2V617F myeloproliferative neoplasms
David Kealy, Ruth Ellerington, Suraj Bansal, et al.
(2024)
Closed Access
David Kealy, Ruth Ellerington, Suraj Bansal, et al.
(2024)
Closed Access
The deubiquitinase USP9X regulates RIT1 protein abundance and oncogenic phenotypes
Amanda K. Riley, Michael Grant, Aidan Snell, et al.
iScience (2024) Vol. 27, Iss. 8, pp. 110499-110499
Open Access
Amanda K. Riley, Michael Grant, Aidan Snell, et al.
iScience (2024) Vol. 27, Iss. 8, pp. 110499-110499
Open Access
Mapping kinase domain resistance mechanisms for the MET receptor tyrosine kinase via deep mutational scanning
Gabriella O. Estevam, Edmond M. Linossi, J. N. K. Rao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Gabriella O. Estevam, Edmond M. Linossi, J. N. K. Rao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
